ACS GCI Pharmaceutical Roundtable
In 2005, the ACS Green Chemistry Institute® (ACS GCI) and global pharmaceutical corporations developed the ACS GCI Pharmaceutical Roundtable (Roundtable) to encourage innovation while catalyzing the integration of green chemistry and green engineering in the pharmaceutical industry. The activities of the Roundtable reflect the joint belief that the pursuit of green chemistry and green engineering is imperative for a sustainable business and world environment.
Recent News
- New article by Roundtable Members: “Green Chemistry Articles of Interest to the Pharmaceutical Industry,” Andrews, et. al., Organic Process Research & Development 2009 13 (3), 397-408.
- “Pharma goes green to cut costs”
- ACS, Pharma Initiative Awards Additional Grant: Joint effort targets more efficient Suzuki C–C coupling reactions that partially avoid halogenated aromatics
- Key green chemistry research areas: A perspective from pharmaceutical manufacturers
Mission
The Roundtable's mission is to catalyze the implementation of green chemistry and green engineering in the global pharmaceutical industry.
Strategic Priorities
To achieve this mission, the Roundtable identified four strategic priorities:
- Inform and Influence the Research Agenda
- Tools for Innovation
- Education Resource
- Global Collaboration
Open Invitation
The ACS GCI Pharmaceutical Roundtable invites all pharmaceutical research, development, and manufacturing companies to consider membership in the Roundtable.
To participate in the Roundtable or for more information on the Roundtable, please contact gcipr@acs.org or call (202) 872-6102.